FC

Finepoint Capital Portfolio holdings

AUM $543M
1-Year Est. Return 12.25%
This Quarter Est. Return
1 Year Est. Return
+12.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$262M
AUM Growth
-$47.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$2.36M
2
+$2.16M
3
+$2.1M
4
ARVN icon
Arvinas
ARVN
+$1.71M
5
SLDB icon
Solid Biosciences
SLDB
+$1.28M

Top Sells

1
+$20.4M
2
+$9.88M
3
+$4.9M
4
TVTX icon
Travere Therapeutics
TVTX
+$3.4M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$3.38M

Sector Composition

1 Healthcare 99.25%
2 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$67.1K 0.03%
548,000
27
$61.1K 0.02%
366,666
28
$60.1K 0.02%
358,270
29
$60.1K 0.02%
387,249
30
$59.9K 0.02%
490,000
31
$59.8K 0.02%
459,906
32
$59.4K 0.02%
540,000
33
$53.6K 0.02%
334,666
34
$51.3K 0.02%
1,014,000
35
$28.6K 0.01%
408,333
36
$26.9K 0.01%
655,200
37
$23.9K 0.01%
183,749
38
$18.1K 0.01%
361,756
39
– –
-3,219,441
40
– –
-1,545,589
41
– –
-274,999
42
– –
-489,999
43
– –
-862,499
44
– –
-336,666
1
2